Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896416962> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2896416962 endingPage "e574" @default.
- W2896416962 startingPage "e573" @default.
- W2896416962 abstract "We previously reported the feasibility of intensity modulated proton postmastectomy radiotherapy (P-PMRT) in women with immediate tissue expander (TE) reconstruction with metallic ports. Our purpose is to analyze early complication rates and patient reported outcomes of this novel treatment approach. All patients underwent mastectomy, axillary staging, and immediate TE placement. P-PMRT was delivered to the chest wall and regional lymphatics, including the internal mammary nodes, to a median dose of 50 Gy (RBE1.1) in 25 fractions with a median of two multifield optimized beams. Second-stage implant or autologous reconstruction took place a minimum of 6 months after the completion of P-PMRT. Adverse effects, patient-reported quality of life (QOL), and breast cosmesis were prospectively-assessed with the CTCAEv4.0, linear analog 10-point scales, and the Harvard Breast Cosmesis Scale, respectively. Between 2015 and 2017, 53 patients underwent mastectomy with immediate TE reconstruction followed by P-PMRT. TE placement was prepectoral in 40 (75%) and subpectoral in 13 (25%). Forty patients (75%) underwent contralateral prophylactic mastectomy with TE reconstruction. Median age was 49 (interquartile range [IQR] 43-57). The tumor was left-sided in 36 (68%), right-sided in 14 (26%), and bilateral in 3 (6%). Chemotherapy [neoadjuvantly (68%) or adjuvantly (15%)] was delivered in 44 (83%) patients, prior to P-PMRT. Median time from surgery to initiation of P-PMRT in the 45 patients who did not receive adjuvant chemotherapy was 59 days (IQR 53 - 71). The median mean heart dose and ipsilateral lung V20 Gy was 0.65 Gy (IQR 0.44 - 0.92) and 13.9 % (IQR 10.3% - 15.3%), respectively. Maximal acute dermatitis grade was 1 in 60%, 2 in 26%, and 3 in 8%. Median follow-up after P-PMRT was 8 months. Six of 56 (11%) irradiated and 1 (3%) non-irradiated implants had been removed due to complications. Other reconstruction complications are shown in the table. QOL was reported as ≥7 in 75% at baseline prior to P-PMRT initiation, with improvement to 83% at 6-months post-treatment. Eighty-six percent of responding patients reported good or excellent cosmesis at 6-month follow-up. Early toxicity and patient reported outcomes of P-PMRT appear favorable in patients with immediate TE reconstruction, although complications remain higher on irradiated vs non-irradiated sides. Intensity modulated P-PMRT is a promising cardiopulmonary sparing modality for women with immediate reconstruction.Abstract TU_2_3341; Table 1ComplicationsIrradiated, n = 53Non-irradiated, n= 43Total19 (36%)2 (5%) Prior to P-PMPT2 (4%)2 (5%) <30 days after completion of P-PMPT2 (4%)0Infection >30 days of P-PMPT to second stage procedure7 (13%)0 After second stage procedure4 (8%)0Implant removal6 (11%)1 (2%)Seroma4 (8%)0Mastectomy skin flap necrosis2 (4%)0Capsular contracture1 (2%)0 Open table in a new tab" @default.
- W2896416962 created "2018-10-26" @default.
- W2896416962 creator A5001361412 @default.
- W2896416962 creator A5006321078 @default.
- W2896416962 creator A5020773196 @default.
- W2896416962 creator A5024662261 @default.
- W2896416962 creator A5033323953 @default.
- W2896416962 creator A5033544737 @default.
- W2896416962 creator A5034530227 @default.
- W2896416962 creator A5040197178 @default.
- W2896416962 creator A5044939667 @default.
- W2896416962 creator A5047133665 @default.
- W2896416962 creator A5052933129 @default.
- W2896416962 creator A5073849902 @default.
- W2896416962 creator A5073902950 @default.
- W2896416962 creator A5081967642 @default.
- W2896416962 creator A5083871900 @default.
- W2896416962 date "2018-11-01" @default.
- W2896416962 modified "2023-09-27" @default.
- W2896416962 title "Early Toxicity and Patient Reported Outcomes of Post-Mastectomy Pencil-Beam Scanning Proton Therapy in Women with Immediate Tissue Expander Breast Reconstruction" @default.
- W2896416962 doi "https://doi.org/10.1016/j.ijrobp.2018.07.1587" @default.
- W2896416962 hasPublicationYear "2018" @default.
- W2896416962 type Work @default.
- W2896416962 sameAs 2896416962 @default.
- W2896416962 citedByCount "0" @default.
- W2896416962 crossrefType "journal-article" @default.
- W2896416962 hasAuthorship W2896416962A5001361412 @default.
- W2896416962 hasAuthorship W2896416962A5006321078 @default.
- W2896416962 hasAuthorship W2896416962A5020773196 @default.
- W2896416962 hasAuthorship W2896416962A5024662261 @default.
- W2896416962 hasAuthorship W2896416962A5033323953 @default.
- W2896416962 hasAuthorship W2896416962A5033544737 @default.
- W2896416962 hasAuthorship W2896416962A5034530227 @default.
- W2896416962 hasAuthorship W2896416962A5040197178 @default.
- W2896416962 hasAuthorship W2896416962A5044939667 @default.
- W2896416962 hasAuthorship W2896416962A5047133665 @default.
- W2896416962 hasAuthorship W2896416962A5052933129 @default.
- W2896416962 hasAuthorship W2896416962A5073849902 @default.
- W2896416962 hasAuthorship W2896416962A5073902950 @default.
- W2896416962 hasAuthorship W2896416962A5081967642 @default.
- W2896416962 hasAuthorship W2896416962A5083871900 @default.
- W2896416962 hasBestOaLocation W28964169621 @default.
- W2896416962 hasConcept C119060515 @default.
- W2896416962 hasConcept C121608353 @default.
- W2896416962 hasConcept C126322002 @default.
- W2896416962 hasConcept C141071460 @default.
- W2896416962 hasConcept C2777757722 @default.
- W2896416962 hasConcept C2780943399 @default.
- W2896416962 hasConcept C2781001896 @default.
- W2896416962 hasConcept C2781411149 @default.
- W2896416962 hasConcept C509974204 @default.
- W2896416962 hasConcept C530470458 @default.
- W2896416962 hasConcept C71924100 @default.
- W2896416962 hasConceptScore W2896416962C119060515 @default.
- W2896416962 hasConceptScore W2896416962C121608353 @default.
- W2896416962 hasConceptScore W2896416962C126322002 @default.
- W2896416962 hasConceptScore W2896416962C141071460 @default.
- W2896416962 hasConceptScore W2896416962C2777757722 @default.
- W2896416962 hasConceptScore W2896416962C2780943399 @default.
- W2896416962 hasConceptScore W2896416962C2781001896 @default.
- W2896416962 hasConceptScore W2896416962C2781411149 @default.
- W2896416962 hasConceptScore W2896416962C509974204 @default.
- W2896416962 hasConceptScore W2896416962C530470458 @default.
- W2896416962 hasConceptScore W2896416962C71924100 @default.
- W2896416962 hasIssue "3" @default.
- W2896416962 hasLocation W28964169621 @default.
- W2896416962 hasOpenAccess W2896416962 @default.
- W2896416962 hasPrimaryLocation W28964169621 @default.
- W2896416962 hasRelatedWork W1979876963 @default.
- W2896416962 hasRelatedWork W2009593042 @default.
- W2896416962 hasRelatedWork W2017094823 @default.
- W2896416962 hasRelatedWork W2140042293 @default.
- W2896416962 hasRelatedWork W2159016681 @default.
- W2896416962 hasRelatedWork W2397516145 @default.
- W2896416962 hasRelatedWork W2765523009 @default.
- W2896416962 hasRelatedWork W2923237854 @default.
- W2896416962 hasRelatedWork W3016928775 @default.
- W2896416962 hasRelatedWork W1896896856 @default.
- W2896416962 hasVolume "102" @default.
- W2896416962 isParatext "false" @default.
- W2896416962 isRetracted "false" @default.
- W2896416962 magId "2896416962" @default.
- W2896416962 workType "article" @default.